Evidence map›Paper›PMID 39539607›Full record

ArticleThe Canadian journal of hospital pharmacy2024

Nawres Makhlouf, Imen Ben Jedidia, Marwa Bel Haj Ali, Mariem Chedly, Amani Cherif

Abstract readEnglish Abstract
In one paragraph

Article in The Canadian journal of hospital pharmacy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nawres Makhlouf, Pharm. D., Faculté de Pharmacie de Monastir, Université de Monastir, Monastir, Tunisie.
Imen Ben Jedidia, Pharm. D., Ph. D., Faculté de Pharmacie de Monastir, Université de Monastir; et Département de pharmacie B du centre de Maternité et de néonatologie, Hôpital Universitaire Fattouma Bourguiba, Monastir, Tunisie.
Marwa Bel Haj Ali, Pharm. D., Faculté de Pharmacie de Monastir, Université de Monastir, Monastir, Tunisie.
Mariem Chedly, Pharm. D., Faculté de Pharmacie de Monastir, Université de Monastir, Monastir, Tunisie; Service de pharmacie de l'Hôpital Universitaire Habib Thameur, Tunis, Tunisie.
Amani Cherif, Pharm. D., Ph. D., Faculté de Pharmacie de Monastir, Université de Monastir; et Département de pharmacie B du Centre de Maternité et de Néonatologie, Hôpital Universitaire Fattouma Bourguiba, Monastir, Tunisie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Alternative and complementary medicines are currently experiencing a real boom worldwide, especially among cancer patients who are looking to improve their physical and mental well-being. Objectives: To provide an overview of the use of traditional treatments and dietary supplements by cancer patients and to assess the impact of these approaches on cancer care. Methods: This prospective cross-sectional descriptive study was conducted at the oncology day hospital of a Tunisian medical centre. Data were collected from February 1 to March 30, 2022. Results: In the study population, the prevalence of complementary medicine use was 71%; users were predominantly female, and average age was 54 years. Herbal medicine was most commonly used (69.7%); animal-derived products, diet, massage therapy, and dietary supplements were also common, with percentages ranging between 20% and 40%. Cupping therapy (12.4%) and mind-body therapies (such as rokia charia and physical activity; 10%) were noted to a lesser extent. Of the plants identified, the most frequently consumed was Conclusions: The survey revealed a significant prevalence of alternative medicine use, which requires careful attention and further research.

Indexed as

cancercomplementary and alternative medicineherbal medicineintegrative oncologyinteraction

Identifiers

PMID39539607
PMCPMC11507552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.